CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing.
Timeline
February 2020
Collplant raises a $4,500,000 venture round.
September 2019
Collplant raises a $5,500,000 venture round.
September 2017
Collplant raises a $5,000,000 venture round.
December 2013
Collplant raises a $1,000,000 venture round.
November 2007
Collplant raises a $7,400,000 venture round from Ami Sagi and Meitav Investment House.
August 12, 2004
Collplant was founded by Oded Shoseyov.
Funding rounds
People
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
News
Title
Author
Date
Publisher
Description
CollPlant
June 4, 2021
www.prnewswire.com:443
/PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, announced today the uplisting of its ordinary shares to the Nasdaq...
CollPlant
March 4, 2021
www.prnewswire.com:443
/PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company, today announced that Mr. Yehiel Tal, Chief Executive Officer of...
CollPlant
February 25, 2021
www.prnewswire.com:443
/PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN) a regenerative and aesthetics medicine company, today announced that on February 24, 2021 it received...
References
Is a
Company attributes
Location
Company status
Active
B2X
Founder
Crunchbase
Legal name
CollPlant Biotechnologies Ltd.
Legal classification
Date incorporated
August 12, 2004
Number of Employees (ranges)
20 – 49
Full address
4 Oppenheimer REHOVOT , 7670104 Israel
CIK number
Total funding amount (USD)
39,700,000
Latest funding round date
February 2020
Latest funding type
Other attributes
Country
